Published in Patol Fiziol Eksp Ter on September 04, 2013
[The principles of the therapy of glanders in monkeys]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.83
[Effects of carnosine on systemic hemodynamics and myocardial metabolism in rats in the early postresuscitation period]. Biull Eksp Biol Med (1992) 0.78
[Homeostatic changes in monkeys in a model of glanders]. Antibiot Khimioter (1997) 0.77
[Prevention of impairment of myocardium metabolism and function in immobilization stress using previous adaptation to short stress exposures]. Vopr Med Khim (1985) 0.77
Effect of hypoxia on metabolism and contractile function of the heart in rats with type 2 diabetes mellitus and abdominal obesity. Bull Exp Biol Med (2004) 0.76
[Reperfusion injury of myocardial biomembranes after acute fatal hemorrhage and their correction with carnosine]. Biokhimiia (1992) 0.75
[Diastolic malfunction in sepsis and septic shock]. Anesteziol Reanimatol (2004) 0.75
[Disorders of cardiac contractility caused by hemorrhagic hypotension]. Anesteziol Reanimatol (2000) 0.75
[Clinical significance of the parameters of a systemic inflammatory response, leukocytic intoxication index, and procalcitonin test in the diagnosis of pyodestructive pyelonephritis of pregnant women]. Anesteziol Reanimatol (2008) 0.75
[Disorders of purine metabolism in patients with peritonitis complicated by sepsis]. Anesteziol Reanimatol (2000) 0.75
[Use of inderal for preventing heart damage in mechanical asphyxia accompanied by clinical death]. Patol Fiziol Eksp Ter (1985) 0.75
[Quercetin as an agent to prevent the cardiotoxic action of antituberculosis preparations]. Patol Fiziol Eksp Ter (1986) 0.75
[The use of carnosine for reducing the post-resuscitation damage to the heart following acute fatal blood loss]. Anesteziol Reanimatol (1992) 0.75
[Iron metabolism and its role in traumatic disease]. Anesteziol Reanimatol (2014) 0.75
[Use of the synthetic antioxidant ionol for prevention of post-resuscitation myocardial damage]. Anesteziol Reanimatol (1984) 0.75
[The auditory tube and tympanoplasty]. Vestn Otorinolaringol (1984) 0.75
[Structural basis of impairment of the external respiratory function in the post-resuscitation period]. Arkh Patol (1987) 0.75
[Effect of acute fatal blood loss on peroxidation of myocardial lipids during the postresuscitation period]. Vopr Med Khim (1988) 0.75
[Prevention of functional and metabolic cardiac disorders in acute blood loss with gutimin]. Patol Fiziol Eksp Ter (1986) 0.75
[Systemic inflammation complication of acute coronary syndrome with diabetes mellitua type 2]. Patol Fiziol Eksp Ter (2011) 0.75
[Impaired blood coagulative properties in the early postresuscitation period and their prevention]. Anesteziol Reanimatol (2005) 0.75
[Peculiarities of lower limb varicosity in patients with various levels of functioning of the cardiovascular system]. Angiol Sosud Khir (2007) 0.75
[Effects of clinical death and pre-administered inderal on adrenoreactivity of the heart in post-resuscitation period]. Biull Eksp Biol Med (1990) 0.75
Amylolytic activity of small intestinal brush-border membrane in the late postresuscitation period. Bull Exp Biol Med (2004) 0.75
[Fatal acute hemorrhage and activity of serum and erythrocyte cholinesterase]. Anesteziol Reanimatol (1997) 0.75
[Effect of early post-resuscitation endotoxemia on the myocardial function]. Anesteziol Reanimatol (2004) 0.75
[Use of sodium gamma-hydroxybutyrate to prevent heart damage in acute fatal blood loss]. Anesteziol Reanimatol (1983) 0.75
[Ionol as a drug for the prevention of cardiotoxic effect of antitubercular agents]. Probl Tuberk (1984) 0.75
[The effect of preliminary administration of the beta-blocker inderal on the course of the postresuscitation period]. Anesteziol Reanimatol (1990) 0.75
[Hemodynamic disorders and myocrdial insufficiency after toxic doses of propranolol]. Vestn Ross Akad Med Nauk (2011) 0.75
[Isoptin in the prevention of post-resuscitation damage of the heart]. Patol Fiziol Eksp Ter (1987) 0.75
[Inderal as an agent for preventing postresuscitation heart injuries]. Patol Fiziol Eksp Ter (1989) 0.75
[Changes in coagulation hemostasis in patients after coronary bypass surgery]. Klin Lab Diagn (2008) 0.75
[The membrane-protective effect of carnosine in the post-resuscitation period after acute lethal blood loss]. Vopr Med Khim (1993) 0.75
[Comparative evaluation of different infusion medias used in therapy for neonatal hypovolemia]. Anesteziol Reanimatol (2005) 0.75
[Role of disorders of metabolism in rat myocardium and endotoxemia in the pathogenesis of post-resuscitation cardiodepression]. Patol Fiziol Eksp Ter (1999) 0.75
Heart sensitivity to electrolyte composition of perfusion solution of rats after severe brain injury. Bull Exp Biol Med (2006) 0.75
[Critical conditions as a logical and appropriate series of events in iron methabolism disorders (the summary of experimental studies)]. Biomed Khim (2014) 0.75
[Immunological aspects of postresuscitation damage to the myocardium]. Patol Fiziol Eksp Ter (1987) 0.75
[Clinical management of disorders hemostasis-related with obstetric complications]. Vestn Ross Akad Med Nauk (2014) 0.75
[Study of pathogenesis of Anaprilin toxicological influence in analysis of central hemodynamic indices and myocardial contractility of isolated heart in experiment]. Patol Fiziol Eksp Ter (2012) 0.75
[Effectiveness of oxygen therapy for pulmonary edema in patients with hypertensive crisis before hospitalization]. Anesteziol Reanimatol (2003) 0.75
[Problem of intraoperative hemotransfusion]. Anesteziol Reanimatol (2014) 0.75
[Myocardial contractility after brain injury]. Anesteziol Reanimatol (2006) 0.75
[Prevention of postresuscitation heart damage with gutimine]. Anesteziol Reanimatol (1987) 0.75
Ultrasonic model of acute pancreatitis. Bull Exp Biol Med (2005) 0.75
[Influence of heptral on the functional-metabolic indices of the liver of rats with necrotizing pancreatitis]. Patol Fiziol Eksp Ter (2013) 0.75
[Usefulness of tympanometry in imperforate otitis media]. Vestn Otorinolaringol (1983) 0.75
[Use of neoton and finoptin to correct metabolic disorders of the brain in craniocerebral injuries]. Anesteziol Reanimatol (1999) 0.75
[Use of plasmapheresis for correction of metabolic disorders in patients with surgical sepsis]. Anesteziol Reanimatol (2001) 0.75
[Inderal as a means of preventing damage to vitally important organs in the case of mechanical asphyxiation, accompanied by clinical death]. Anesteziol Reanimatol (1989) 0.75
[The matrix metalloproteinase 9 (MMP-9) and TIMP-1 activities in patients with chronic and recurrent pancreatitis]. Eksp Klin Gastroenterol (2010) 0.75
[Prognostic value of determining the succinate dehydrogenase activity of lymphocytes and the therapeutic effectiveness of sodium succinate in resuscitation of rats]. Biull Eksp Biol Med (1985) 0.75
[A cerebral hernia of the postoperative mastoidal cavity (current aspects of the problem)]. Vestn Otorinolaringol (1990) 0.75
[Use of isoptin in the prevention of post-resuscitation heart damage]. Anesteziol Reanimatol (1987) 0.75
[The use of sodium gamma-oxybutyrate and gutimine for decreasing metabolic disorders in the heart, caused by exotoxic shock in acetic acid poisoning]. Vopr Med Khim (1994) 0.75
[Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus]. Ter Arkh (2010) 0.75
[Prevention with inderal of post-resuscitation impairment of metabolism in heart and brain tissues]. Vopr Med Khim (1990) 0.75
[Atrial fibrillation and condition of vegetative nervous system: features of tactics and medical aid rendering at the pre-hospital stage]. Patol Fiziol Eksp Ter (2015) 0.75
[Introduction of new technologies in teaching basic and clinical pathophysiology]. Patol Fiziol Eksp Ter (2008) 0.75
[The verapamil correction of postresuscitation damages to the heart]. Anesteziol Reanimatol (1997) 0.75
[Effects of immunocorrective therapy on immunological indices in patients with chronic bacterial prostatitis]. Urologiia (2012) 0.75
[Activation of lipid peroxidation processes in the postresuscitation period]. Anesteziol Reanimatol (1988) 0.75
[Activation of lipid peroxidation and its prevention with ionol during mechanical asphyxia followed by resuscitation]. Biull Eksp Biol Med (1983) 0.75
[Use of quercetin to prevent and treat cardiovascular disorders in pulmonary tuberculosis]. Probl Tuberk (1986) 0.75
[Use of succinate dehydrogenase activity of lymphocytes to predict the course of the post-resuscitation period]. Biull Eksp Biol Med (1985) 0.75
[Prevention of post-resuscitation impairment of energy metabolism in the myocardium using sodium gamma-hydroxybutyrate, ionol and gutimine]. Vopr Med Khim (1988) 0.75
[Genesis of systemic changes in hemodynamics in cardiac contusion]. Anesteziol Reanimatol (2009) 0.75
[The antioxidant oxypyridine-6 as an agent for preventing postresuscitation functional metabolic damage to the heart]. Anesteziol Reanimatol (1991) 0.75
[Complex prevention of thrombotic complications in patients with colorectal cancer during different stages of surgical treatment]. Anesteziol Reanimatol (2001) 0.75
[Impact of postoperative early enteral feeding on hemodynamics, oxygen and nutritive status in patients with colonic malignancies concurrent with type 2 diabetes mellitus]. Anesteziol Reanimatol (2008) 0.75
[Treatment of patients with purulent wound infection under conditions of extreme north]. Vestn Khir Im I I Grek (2009) 0.75
[Cardioprotective effect of exogenous creatine phosphate in acute hemorrhage]. Anesteziol Reanimatol (2003) 0.75
[The antioxidant hydroxypyridine-6 as an agent to prevent postresuscitation heart damage]. Patol Fiziol Eksp Ter (1992) 0.75
[Prevention of postresuscitation heart failure by using ionol]. Biull Eksp Biol Med (1983) 0.75
Experimental model of heart contusion. Bull Exp Biol Med (2009) 0.75
[The effect of acute fatal blood loss on post-resuscitation changes in heart phospholipids and prevention of them]. Vopr Med Khim (1991) 0.75
[The pathogenesis and correction of disorders of the heart rhythm in the early post-resuscitation period]. Anesteziol Reanimatol (1993) 0.75
[Prophylaxis of acute pancreatitis during resection of the stomach for "difficult" complicated of duodenal ulcers]. Vestn Khir Im I I Grek (2009) 0.75
[Antioxidant ionol as an agent preventing post-resuscitation cardiac insufficiency]. Patol Fiziol Eksp Ter (1984) 0.75
[Cardiac damage and protection in acute fatal blood loss]. Vestn Ross Akad Med Nauk (2002) 0.75
[Principle energy substrate changing as a technique of myocardium protection against ischemic damage in experimental mechanic cardiac contusion]. Patol Fiziol Eksp Ter (2009) 0.75
[The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome]. Patol Fiziol Eksp Ter (2014) 0.75
[Clinical effects of packed red blood cells transfusion according to storage life and time of transfusion]. Khirurgiia (Mosk) (2014) 0.75
[Possibilities of impedance tests in perforative otitis media]. Vestn Otorinolaringol (1984) 0.75
[Arrest of the chronic pain syndrome using epidural analgesia in patients with disseminated prostate cancer]. Anesteziol Reanimatol (2003) 0.75
[Use of the antioxidant ionol to prevent damage to the heart from prolonged administration of antitubercular preparations]. Biull Eksp Biol Med (1983) 0.75
[Effect of acute fatal blood loss on the functional metabolic disturbances of the heart in the postresuscitation period]. Anesteziol Reanimatol (1989) 0.75
[Iron metabolism in biological systems (biochemical, pathophysiological and clinical aspects)]. Biomed Khim (2007) 0.75
[Immune disturbances in patients with postnecrotic pseudocysts of the pancreas]. Antibiot Khimioter (2012) 0.75
[Disordered cardiac contractility after clinical death caused by acute blood loss]. Anesteziol Reanimatol (1997) 0.75
[Prevention of post-resuscitation metabolic disorders by the antioxidant oxypyridine-6]. Vopr Med Khim (1992) 0.75
[Drainage of the pancreatic duct]. Vestn Khir Im I I Grek (2006) 0.75
[Endotoxemia in hemorrhagic hypotension]. Patol Fiziol Eksp Ter (2009) 0.75
[Can one study pathological physiology independently according to an individual plan?]. Patol Fiziol Eksp Ter (1991) 0.75
[Treatment for urologic polyneoplasia]. Vopr Onkol (2008) 0.75
[Immunologic aspects of myocardial damage during long-term administration of antitubercular preparations]. Probl Tuberk (1983) 0.75
[Iron metabolism disturbance as a marker of the illness severity in the intensive care kind of patients]. Fiziol Cheloveka (2007) 0.75
[Total sequestration of the labyrinth]. Vestn Otorinolaringol (1992) 0.75
[Preventive strategy for atrial fibrillation in arterial hypertension]. Klin Med (Mosk) (2009) 0.75